95 related articles for article (PubMed ID: 12741320)
1. [Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital].
Bogdanov MB; Chernen'kaia TV
Antibiot Khimioter; 2003; 48(1):27-30. PubMed ID: 12741320
[TBL] [Abstract][Full Text] [Related]
2. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Bogdanov MB; Chernen'kaia TV
Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394
[TBL] [Abstract][Full Text] [Related]
3. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Gao B; Hu J; Deng W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
[TBL] [Abstract][Full Text] [Related]
4. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
Lanni N; Scaglione B
Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
[TBL] [Abstract][Full Text] [Related]
5. [Ceftriaxone (Rocefin) in the treatment of bronchopulmonary infections].
Nonikov VE; Konstantinova TD; Makarova OV; Manziuk EN; Minaev VI; Ritchik LA
Ter Arkh; 1997; 69(10):84-8. PubMed ID: 9471801
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
Chang UI; Kim HW; Wie SH
Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
Tempera G; Furneri PM; Carlone NA; Cocuzza C; Rigoli R; Musumeci R; Pilloni AP; Prenna M; Tufano MA; Tullio V; Vitali LA; Nicoletti G
J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418
[TBL] [Abstract][Full Text] [Related]
9. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
Nannini EC; Stryjewski ME; Singh KV; Rude TH; Corey GR; Fowler VG; Murray BE
Antimicrob Agents Chemother; 2010 May; 54(5):2206-8. PubMed ID: 20211890
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
11. Paediatric empyema in New Zealand: a tale of two cities.
Burton C; Walls T; Price N; Glasgow T; Walker C; Beasley S; Best E
N Z Med J; 2015 May; 128(1415):25-33. PubMed ID: 26117509
[TBL] [Abstract][Full Text] [Related]
12. Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone.
Frimodt-Møller N; Bentzon MW; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):261-7. PubMed ID: 3673583
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
Wessels F; Anderson AN; Ebrahim O
S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
Ravizzola G; Bonfanti C; Savoldi E; Turano A
Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
[TBL] [Abstract][Full Text] [Related]
15. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
16. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394
[TBL] [Abstract][Full Text] [Related]
17. [A rare cause of pneumonia: Shewanella putrefaciens].
Durdu B; Durdu Y; Güleç N; Islim F; Biçer M
Mikrobiyol Bul; 2012 Jan; 46(1):117-21. PubMed ID: 22399180
[TBL] [Abstract][Full Text] [Related]
18. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams.
Dajani AS; Pokowski LH
Scand J Infect Dis Suppl; 1990; 73():31-42. PubMed ID: 2091255
[TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Burdet C; Grall N; Linard M; Bridier-Nahmias A; Benhayoun M; Bourabha K; Magnan M; Clermont O; d'Humières C; Tenaillon O; Denamur E; Massias L; Tubiana S; Alavoine L; Andremont A; Mentré F; Duval X;
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936104
[TBL] [Abstract][Full Text] [Related]
20. [Comparative clinical efficacy of cephotaxim and cefuroxime against the pathogens of inflammation in obstetrics and gynecology].
Voropaeva SD; Emel'ianova AI; Ankirskaia AS; Saakian SS; Maĭorova VN
Antibiotiki; 1983 Jun; 28(6):456-61. PubMed ID: 6309078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
